Published • loading... • Updated
West completes sale of on-body drug delivery device to AbbVie
Summary by Drug Delivery Business
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
West completes sale of on-body drug delivery device to AbbVie
The SmartDose 3.5mL on-body delivery system. [Image courtesy of West]West Pharmaceutical Services (NYSE:WST) announced that it completed the sale of its SmartDose on-body delivery system to AbbVie. Exton, Pennsylvania-based West sold and transferred its manufacturing and supply rights for the SmartDose 3.5mL on-body delivery system and associated facilities to AbbVie. The companies closed their transaction, as planned, on July 1, 2026. West will…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
